Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Siemens targets molecular imaging in research pact:

This article was originally published in Clinica

Executive Summary

In a deal that signifies its investment in molecular imaging, Siemens Medical Solutions has agreed to dedicate resources, researchers and technology to the Center for Molecular Imaging Research (CMIR) at Massachusetts General Hospital. The CMIR focuses on combining genetic information and new chemistries to develop imaging probes, which are detectable by imaging technologies, to study diseases, such as cancer, atherosclerosis and rheumatoid arthritis. "The long-term goals of the collaboration are to develop novel technologies for in vivo sensing and imaging of molecular events, and to expand these new tools into clinical applications," says Dr Ralph Weissleder, the CMIR's director.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT063101

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel